By Flavia Fortes (October 17, 2023) -- Pfizer has indicated it won't give the Federal Trade Commission much time to review its acquisition of Seagen, a strategy also adopted by Amgen for its Horizon Therapeutics buy, which resulted in a lawsuit and ultimately a settlement....